Feature | August 28, 2013

Cardiovascular Imaging Protocols for Cancer Patients Announced

August 28, 2013 — Experts have found that radiation dosage can have serious complications for patients with cancer. Cancer patients who receive chest radiation should be evaluated for heart disease before beginning radiation, and every five to 10 years afterward, according to the American Society of Echocardiography (ASE) and the European Assn. of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC). This expert consensus statement on the use of imaging to detect radiation-induced heart disease (RIHD) will be published in the September issue of the Journal of the American Society of Echocardiography (JASE). The writing group was co-chaired by Vuyisile Nkomo, M.D., an echocardiographer from the renowned Mayo Clinic in Rochester, Minn.

When asked about the need for this expert consensus statement, Nkomo said, “In the past, patients received high doses of radiation to the chest to treat breast cancer or lymphoma or esophageal cancer, but without adequate shielding of the heart because we did not know that radiation exposure would lead to premature heart disease. Over the years, the medical community has learned that patients with prior radiation to the chest develop premature heart disease that can involve all structures of the heart, leading to coronary artery disease, myocardial disease, valve disease, conduction system disease and pericardial disease.”

Nkomo continued, “Now that heart disease is a known delayed complication of radiation therapy, the guidelines were written to draw attention to this issue of radiation-induced heart disease (RIHD). And, it is urgent to get this information out and into clinical practice because of the increasing number of cancer survivors who receive radiation therapy to the chest and neck. Echocardiographic screening without indication of cardiovascular disease should not be a common practice in the general patient population, but assessments should be incorporated routinely in the initial care and follow-up of these cancer patients.” This guideline makes recommendations regarding when and how to look for RIHD, and it highlights the complementary nature of the various imaging modalities.

RIHD is estimated to occur in 10-30 percent of patients who receive chest radiotherapy within five to 10 years post-treatment. Modern treatment regimens incorporate lower radiation doses and improved shielding of the heart, but heart disease can still occur. In fact, Nkomo noted, “the improved safety of current treatment therapies means that RIHD may develop at widely varying rates among different populations. Therefore, data demonstrating temporal changes in incidence of RIHD and outcomes in the contemporary era are still needed.”

The full guideline document will be available on the Journal of American Society of Echocardiography (JASE) website (www.onlinejase.com) on Sept. 3, and will be published in the September 2013 print issue.

For more information: www.asecho.org/guidelines



Related Content

GE Ultrasound, GE echo
News | Cardiovascular Ultrasound| November 24, 2015
November 24, 2015 — The American Society of Echocardiography (ASE) announced today that it has launched the Echovatio
ContextVision, RSNA 2015, ultrasound image enhancement, 3-D/4-D

Liver ultrasound enhanced with US PlusView. Image courtesy of ContextVision.

Technology | Ultrasound Imaging| November 20, 2015
At this year’s scientific assembly and annual meeting of the Radiological Society of North America (RSNA),...
Philips, Lumify, smart device ultrasound, U.S. introduction

Image courtesy of Philips

Technology | Ultrasound Imaging| November 19, 2015
Philips announced that Lumify, a smart device ultrasound solution, is available for purchase by licensed healthcare...
Fujifilm Sonosite, iViz ultrasound, mobile visualization, FDA clearance

Image courtesy of Fujifilm

Technology | Ultrasound Imaging| November 19, 2015
Fujifilm SonoSite Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for...
GE Healthcare, ultrasound, RSNA 2015, Logiq E9, Vivid, VScan, Voluson, Invenia, ABUS

Vivid E95 cardiovascular ultrasound system. Image courtesy of GE Healthcare.

News | Ultrasound Imaging| November 16, 2015
November 16, 2015 — At the Radiological Society of North America (RSNA) 2015 annual meeting, GE Healthcare will unvei
Lumason, CMS, ultrasound contrast agent, approval for reimbursement, Bracco
News | Contrast Media| October 21, 2015
Bracco Diagnostics Inc. announced that Lumason was approved by the Centers for Medicare and Medicaid Services (CMS) for...
ContextVision, ultrasound image processing, low latency, portable devices

Image courtesy of Philips

News | Ultrasound Imaging| September 25, 2015
At the 2015 IEEE High Performance Extreme Computing Conference (HPEC ‘15), ContextVision presented new results of...
SHAPE, task force, CT calcium scoring, carotid artery ultrasound, SHAPE Trial advisory meeting
News | CT Angiography (CTA)| September 24, 2015
SHAPE, The Society for Heart Attack Prevention and Eradication, met with an international contingent of leading...
Frost & Sullivan, top medical technologies, growth, healthcare

Corindus CorPath Vascular Robotic System image courtesy of Corindus Vascular Robotics.

Feature | Information Technology| September 22, 2015
Frost & Sullivan released its list of top medical technologies for 2015, featuring an array of sophisticated...
DOPPLER-CIP trial, ESC 2015, heart failure, predictor, small left ventricle, University of Leuven
Feature | Heart Failure| September 02, 2015
Findings presented at the European Society of Cardiology (ESC) Congress 2015 indicate that a small left ventricle with...
Overlay Init